Stock Snapshot

{{stockQuote.companyFullName}}
{{stockQuote.quoteInfo}}
{{stockQuote.valueFormatted}}
{{getFormattedValue(stockQuote.changesValueFormatted)}} ({{getFormattedValue(stockQuote.changesPercentFormatted)}}%)
{{getFormattedDateTime(stockQuote.delayDate)}}
{{stockQuote.onlyDateFormatted}} (At Close)
Previous Close
{{todayDetailedInformation.previousClose}}
Volume
{{todayDetailedInformation.volume}}
Today’s Open
{{todayDetailedInformation.todaysOpen}}
Average Volume (10 days)
{{detailQuote.averageVolume}}
Day's Range
{{todayDetailedInformation.todaysLow}} - {{todayDetailedInformation.todaysHigh}}
Market Cap
{{detailQuote.marketCap}}
52 Week Range
{{detailQuote.weekLow}} -{{detailQuote.weekHigh}}
Total Shares Outstanding
{{detailQuote.totalSharesOutstanding}}
More Info

Latest Company Reports

View All SEC Filings

Latest Press Releases

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment

{{getFormattedDate('2024-11-13T09:00:00.0000000')}}
View Press Release View All News

Company Profile

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Sector

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Industry